can't read?
Auranofin inhibits both leukocyte activation pathways at multiple sites and the release of inflammatory mediators from human macrophages, basophils, and pulmonary mast cells.
A 3305 (OTTO) Auranofin, for HPLC ≥98% Cas 34031-32-8 - used to study the anti-proliferative effects against OVCAR-3 human ovarian carcinoma cells.